Ciccarelli, Michele
University of Salerno
6 papers on CoChatORCID 0000-0003-2379-1960
Most cited papers
- Verified
Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation
Kolijn, D., Pabel, S., Tian, Y., Lódi, M., Herwig, M., Carrizzo, A., Zhazykbayeva, S., Kovács, Á., Fülöp, G. Á., Falcão-Pires, I., et al. (2021) · Cardiovascular Research
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 323
- Verified
Exercise promotes angiogenesis and improves β-adrenergic receptor signalling in the post-ischaemic failing rat heart
Leosco, D., Rengo, G., Iaccarino, G., Golino, L., Marchese, M., Fortunato, F., Zincarelli, C., Sanzari, E., Ciccarelli, M., Galasso, G., et al. (2008) · Cardiovascular Research
Cardiovascular and exercise physiologyCardiac Fibrosis and Remodeling
Cited by 131
- Verified
Adrenergic receptors and metabolism: role in development of cardiovascular disease
Ciccarelli, M., Santulli, G., Pascale, V., Trimarco, B., & Iaccarino, G. (2013) · Frontiers in Physiology
Receptor Mechanisms and SignalingCardiovascular Function and Risk Factors
Cited by 89
- Verified
Wearable Technologies and AI at the Far Edge for Chronic Heart Failure Prevention and Management: A Systematic Review and Prospects
Shumba, A.-T., Montanaro, T., Sergi, I., Bramanti, A., Ciccarelli, M., Rispoli, A., Carrizzo, A., De Vittorio, M., & Patrono, L. (2023) · Sensors
IoT and Edge/Fog ComputingInternet of Things and AI
Cited by 74
- Verified
Parathyroid Hormone Causes Endothelial Dysfunction by Inducing Mitochondrial ROS and Specific Oxidative Signal Transduction Modifications
Gambardella, J., De Rosa, M., Sorriento, D., Prevete, N., Fiordelisi, A., Ciccarelli, M., Trimarco, B., De Luca, N., & Iaccarino, G. (2018) · Oxidative Medicine and Cellular Longevity
Nitric Oxide and Endothelin EffectsParathyroid Disorders and Treatments
Cited by 58
- Verified
Anti-inflammation and anti-oxidation: the key to unlocking the cardiovascular potential of SGLT2 Inhibitors and GLP1 receptor agonists
Myasoedova, V. A., Bozzi, M., Valerio, V., Moschetta, D., Massaiu, I., Rusconi, V., Di Napoli, D., Ciccarelli, M., Parisi, V., Agostoni, P., et al. (2023) · Antioxidants
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 35
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free